Keyphrases
Response to Neoadjuvant Therapy
78%
Overall Survival
70%
Tumor Microenvironment
61%
T Cells
59%
Mesothelioma
58%
Tumor Thickness
58%
Patient Selection
52%
Natural Killer Cells
45%
Radiological Response
43%
Neoadjuvant Therapy
43%
Cytoreductive Surgery
43%
Oxidative Phosphorylation (OXPHOS)
43%
Malignant Pleural Mesothelioma
43%
Trp53
39%
Metabolic Reprogramming
39%
Tripartite Motif (TRIM) Proteins
39%
Finger Control
39%
Genetic Engineering
39%
Tumor Development
39%
Metastatic Melanoma
39%
Differential Response
39%
Cancer Stem Cells
39%
Stem Cell Population
39%
Mitochondrial Complex I
39%
Anticancer Immunity
39%
Breast Tumor
39%
Murine Model
39%
Bivalent Chromatin
39%
Immune Landscape
39%
Human Glioma
39%
Glioma
39%
Pten
39%
Multidomain Protein
39%
Progression-free Survival
39%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
39%
Tumor-infiltrating Lymphocyte Therapy
39%
Notch1
39%
Hazard Ratio
31%
Confidence Interval
31%
Neutrophils
27%
Tumor
26%
Tumor-infiltrating Lymphocytes
26%
Free Response
26%
Response to Therapy
26%
PDE1C
26%
Checkpoint Inhibitors
23%
Single-cell RNA Sequencing (scRNA-seq)
22%
Cox Regression Analysis
19%
Macroscopic Complete Resection
19%
Partial Response
19%
Biochemistry, Genetics and Molecular Biology
Reprogramming
86%
Genomics
86%
T Cell
78%
RNA Sequence
54%
DNA Methylation
54%
Epigenetics
50%
Gene Expression
43%
Carcinogenesis
43%
Oxidative Phosphorylation
43%
Gene Regulatory Network
39%
Mesenchymal-Epithelial Transition
39%
Epigenetic Repression
39%
Dynamics
39%
Cancer Stem Cell
39%
Zinc Finger Motif
39%
Cancer Genomics
39%
Pan-cancer
39%
Cisplatin
39%
Transcription Intermediary Factor 1 Beta
39%
Protein Motif
39%
Protein Tertiary Structure
39%
Genome Sequencing
39%
Stem Cell
39%
Tumor-Infiltrating Lymphocytes
39%
Bivalent Chromatin
39%
Self Control
39%
Next Generation Sequencing
39%
Enhancer Region
39%
Anticancer
39%
KEAP1
39%
Blood Plasma
39%
Glutamine
32%
Overall Survival
31%
Progression Free Survival
31%
Malignant Transformation
28%
Tumor Progression
24%
Exome Sequencing
20%
Glutaminase
19%
Natural Killer Cell
19%
Cytotoxic T Cell
19%
Immunocompetent Cell
19%
Dendritic Cell
19%
Transcriptomics
16%
PDE1C
15%
Methylation
15%
CpG Island
15%
Quality Control
13%
Wild Type
13%
Enzyme
13%
Western Blot
13%
Medicine and Dentistry
Neoplasm
100%
Neoadjuvant Therapy
78%
Tumor Microenvironment
52%
Overall Survival
50%
Mesothelioma
48%
T Cell
48%
Patient Selection
46%
Immunity
46%
Pleura Mesothelioma
42%
Biological Marker
42%
Breast Tumor
39%
Cell Population
39%
Protein Tertiary Structure
39%
Tumor Infiltrating Lymphocyte
39%
Cisplatin
39%
Metastatic Melanoma
39%
Metastatic Carcinoma
39%
Head and Neck Squamous Cell Carcinoma
39%
Transcription Intermediary Factor 1 Beta
39%
Immunotherapy
39%
Cancer Stem Cell
39%
Ganglioglioma
39%
Neurofibromatosis Type I
39%
Malignant Peripheral Nerve Sheath Tumor
39%
DNA Methylation
39%
Natural Killer Cell
32%
Progression Free Survival
31%
Distant Metastasis
23%
Diseases
20%
Hazard Ratio
19%
Neutrophil
19%
Cytotoxic T-Cell
15%
Exome Sequencing
15%
Immunocompetent Cell
15%
Tumor Cell
15%
Tumor Progression
15%
Dendritic Cell
15%
RNA Sequence
15%
Surgery
14%
B Cell
13%
Progressive Disease
13%
Proportional Hazards Model
13%
In Vitro
11%
Cell Signaling Pathway
11%
Breast Cancer
11%
Glioblastoma
11%
Methylation
10%
Logistic Regression Analysis
9%
Plexiform Neurofibroma
9%
Glutaminase
7%